CANVAC® R
Suspension for injection
The vaccine is designed for an active immunization of target species against rabies.
Each one dose (1 ml) contains:
Active substance: Virus rabiei inactivatum NLT 2 IU.
Adjuvant: aluminium hydroxide gel 1.4 – 6.5 mg.
Excipient: thiomersal NMT 0.1 mg.
Indications
The vaccine is designed for an active immunization of target species against rabies.
Sufficient immunity develops over 2 to 3 weeks after the basic vaccination. After re-vaccination, the immunity persists for at least 1 year.
Contraindications
Do not use in cases of an acute infectious disease, an organ and feverish disease, detection of an unfavorable post-vaccination reaction or allergy at former vaccinations and after stress imposed on animals (transportation, high environmental temperatures). Do not use at pregnant animals at a high stage of pregnancy and close after parturition. It is forbidden to immunize animals ill with rabies or animals, which have been in contact with or hurt by animals suffering from rabies. Animals, which injured the man, may be immunized only after the period of observation has elapsed.
Dosage and method of administration
The immunization dose per 1 animal is 1 ml, irrespective of species, age, sex and weight. Dogs, cats, fur-coat animals, cattle, sheep, goats and horses should be treated subcutaneously (s.c.). Pigs are immunized intramuscularly (i.m.) at the site of the neck, behind the ear.
In general, administration of one dose is sufficient to obtain immunity in adult animals. To maintain long-term immunity, regular annual re-vaccinations are necessary. It is recommended to administer the second dose to young animals of unknown origin 2-4 weeks after the first dose, regardless their colostral immunity and age.
The basic vaccination:
At carnivores that come from immunized mothers and received colostrum is recommended to administer one dose to youngsters at the age of approximately 5 months. It is advisable to administer the first dose to youngsters, born to unvaccinated mothers, at the age of approximately
1 month. In case that youngsters are vaccinated within the age of 5 months, it is advisable to administer the second dose after 4-6 weeks.
It is advisable to administer one dose to youngsters of the even-toed and odd-toed animals after disappearance of colostral immunity, depending on the animal species, mostly at the age of 3-9 months. To youngsters born to unvaccinated mothers is advisable to administer the first dose at age of approximately 2 months. It is advisable to administer the second dose after 2-4 weeks.
Re-vaccination:
Regular annual revaccination is advisable to maintain the permanent immunity.
Size of package: 12 x 1 dose, 60 x 1 dose, 5 x 10 doses, 1 x 20 doses, 5 x 20 doses, 1 x 50 doses
Not all pack sizes may be marketed.
For animals only. Veterinary medicinal product to be supplied only on veterinary prescription.